000 01446 a2200457 4500
005 20250512200412.0
264 0 _c19841106
008 198411s 0 0 eng d
022 _a0302-282X
024 7 _a10.1159/000118064
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWoggon, B
245 0 0 _aAntipsychotic efficacy of fluperlapine. An open multicenter trial.
_h[electronic resource]
260 _bNeuropsychobiology
_c1984
300 _a116-20 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aDibenzazepines
_xtherapeutic use
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aElectroencephalography
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aPsychotic Disorders
_xdrug therapy
650 0 4 _aSchizophrenia
_xdrug therapy
650 0 4 _aSchizophrenic Psychology
700 1 _aAngst, J
700 1 _aBartels, M
700 1 _aHeinrich, K
700 1 _aHippius, H
700 1 _aKoukkou, M
700 1 _aKrebs, E
700 1 _aKüfferle, B
700 1 _aMüller-Oerlinghausen, B
700 1 _aPöldinger, W
773 0 _tNeuropsychobiology
_gvol. 11
_gno. 2
_gp. 116-20
856 4 0 _uhttps://doi.org/10.1159/000118064
_zAvailable from publisher's website
999 _c6148782
_d6148782